Form 483 · FEI 3002889358

Form 483 issued August 25, 2022 · Branchburg, New Jersey

Inspection
Jul 26 – Aug 25, 2022
Observations
2
Pages
2
FEI number
3002889358

In short: On August 25, 2022, FDA issued a Form 483 with 2 observations to an FDA-inspected site in Branchburg, New Jersey (FEI 3002889358) after an inspection that ran Jul 26 – Aug 25, 2022. The investigators were Edmund F. Mrak Jr and Kathleen M. Jordan. Most observations concern quality system and laboratory controls; the most-cited regulation is 21 CFR 211.160 (general requirements).

At a glance

Quality system and laboratory controls account for 2 of 2 observations.

Quality system1
Laboratory controls1

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    There is a failure to control the disposition and availability of drug su bstances determined to…

  2. 02

    There is a failure to adequately document, explain, and investigate all deviat ions…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at an FDA-inspected site?

FDA listed 2 observations on this Form 483, mostly about quality system and laboratory controls. The most-cited regulation is 21 CFR 211.160 (general requirements). The opening words of each observation are shown on this page.

Who inspected an FDA-inspected site?

Edmund F. Mrak Jr and Kathleen M. Jordan are named on this Form 483, for the inspection of Jul 26 – Aug 25, 2022. Each investigator has a profile showing what they cite most.

When was an FDA-inspected site inspected by FDA?

The inspection ran Jul 26 – Aug 25, 2022, and the Form 483 is dated August 25, 2022.

How do I get the full Form 483 for an FDA-inspected site?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free